The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. The first in the series, PARPi: Precision Medicine in Advanced Prostate Cancer features a multidisciplinary panel, including a urologist, oncologist, and APP, to present the latest advances in PARPi. The expert faculty will engage in an interactive, case-based discussion amongst each other and engage with the learners through Q&A.
Following this live virtual activity, the course will be captured and posted on AUA’s online learning system, AUAUniversity, and the AUAUniversity YouTube channel for on-demand viewing for up to one year. Additionally, the recording will be released as an individual episode on the very successful AUAUniversity Podcast.
Participants will be asked to complete a Pre-work Library in advance of attending the live virtual courses. The Pre-work Library will include relevant AUA Clinical Guidelines, journal articles and the webcast/podcast of “The Role of PARP Inhibitors in Advanced Prostate Cancer: An AUA/SUO Joint Symposium” presented at the 2023 AUA Annual Meeting.
